🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
Updated 04 Jul 2026 · HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market — 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
491 results for “Novo”
MedicineActive substanceLicence holderStatus
Vardenafil Krka 10 mg film-coated tablets
PA1347/073/002
VARDENAFIL HYDROCHLORIDE TRIHYDRATE KRKA, d.d., Novo mesto Not marketed
Vardenafil Krka 20 mg film-coated tablets
PA1347/073/003
VARDENAFIL HYDROCHLORIDE TRIHYDRATE KRKA, d.d., Novo mesto Not marketed
Vardenafil Krka 5mg film-coated tablets
PA1347/073/001
VARDENAFIL HYDROCHLORIDE TRIHYDRATE KRKA, d.d., Novo mesto Not marketed
Venlafex XL 150 mg prolonged-release capsules, hard
PA1347/036/003
Venlafaxine hydrochloride KRKA, d.d., Novo mesto Marketed
Venlafex XL 37.5 mg prolonged-release capsules, hard
PA1347/036/001
Venlafaxine hydrochloride KRKA, d.d., Novo mesto Marketed
Venlafex XL 75 mg prolonged-release capsules, hard
PA1347/036/002
Venlafaxine hydrochloride KRKA, d.d., Novo mesto Marketed
Victoza 6 mg/ml solution for injection in pre-filled pen
EU/1/09/529/1-5
Liraglutide Novo Nordisk A/S
Vildagliptin Krka 50 mg tablets
PA1347/076/001
Vildagliptin KRKA, d.d., Novo mesto Not marketed
Vizarsin 100 mg film-coated tablets
EU/1/09/551/9-12
Sildenafil KRKA, d.d., Novo mesto
Vizarsin 100 mg orodispersible tablets
EU/1/09/551/023-027
Sildenafil KRKA, d.d., Novo mesto
Vizarsin 25 mg film-coated tablets
EU/1/09/551/1-4
Sildenafil KRKA, d.d., Novo mesto
Vizarsin 25 mg orodispersible tablets
EU/1/09/551/013-017
Sildenafil KRKA, d.d., Novo mesto
Vizarsin 50 mg film-coated tablets
EU/1/09/551/5-8
Sildenafil KRKA, d.d., Novo mesto
Vizarsin 50 mg orodispersible tablets
EU/1/09/551/018-022
Sildenafil KRKA, d.d., Novo mesto
Vortioxetine Krka 10 mg film-coated tablets
PA1347/121/002
Vortioxetine hydrobromide KRKA, d.d., Novo mesto Not marketed
Vortioxetine Krka 15 mg film-coated tablets
PA1347/121/003
Vortioxetine hydrobromide KRKA, d.d., Novo mesto Not marketed
Vortioxetine Krka 20 mg film-coated tablets
PA1347/121/004
Vortioxetine hydrobromide KRKA, d.d., Novo mesto Not marketed
Vortioxetine Krka 5 mg film-coated tablets
PA1347/121/001
Vortioxetine hydrobromide KRKA, d.d., Novo mesto Not marketed
Wegovy 0.25 mg Solution for injection
EU/1/21/1608/001
Semaglutide Novo Nordisk A/S
Wegovy 0.25 mg Solution for injection
EU/1/21/1608/006
Semaglutide Novo Nordisk A/S
Wegovy 0.5 mg Solution for injection
EU/1/21/1608/002
Semaglutide Novo Nordisk A/S
Wegovy 0.5 mg Solution for injection
EU/1/21/1608/007/012
Semaglutide Novo Nordisk A/S
Wegovy 1 mg Solution for injection
EU/1/21/1608/003
Semaglutide Novo Nordisk A/S
Wegovy 1 mg Solution for injection
EU/1/21/1608/008
Semaglutide Novo Nordisk A/S
Wegovy 1.7 mg Solution for injection
EU/1/21/1608/004
Semaglutide Novo Nordisk A/S
Wegovy 1.7 mg Solution for injection
EU/1/21/1608/009
Semaglutide Novo Nordisk A/S
Wegovy 2.4 mg Solution for injection
EU/1/21/1608/005
Semaglutide Novo Nordisk A/S
Wegovy 2.4 mg Solution for injection
EU/1/21/1608/010-011
Semaglutide Novo Nordisk A/S
Xultophy 100 units/mL + 3.6 mg/mL solution for injection.
EU/1/14/947/001-004
Insulin degludec, Liraglutide Novo Nordisk A/S
Zalasta 10 mg Orodispersible tablet
EU/1/07/415/42-46
Olanzapine KRKA, d.d., Novo mesto
Zalasta 10 mg Tablet
EU/1/07/415/16-21
Olanzapine KRKA, d.d., Novo mesto
Zalasta 15 mg Orodispersible tablet
EU/1/07/415/47-51
Olanzapine KRKA, d.d., Novo mesto
Zalasta 15 mg Tablet
EU/1/07/415/22-26
Olanzapine KRKA, d.d., Novo mesto
Zalasta 2.5 mg Tablet
EU/1/07/415/1-5
Olanzapine KRKA, d.d., Novo mesto
Zalasta 20 mg Orodispersible tablet
EU/1/07/415/52-56
Olanzapine KRKA, d.d., Novo mesto
Zalasta 20 mg Tablet
EU/1/07/415/27-31
Olanzapine KRKA, d.d., Novo mesto
Zalasta 5 mg Orodispersible tablet
EU/1/07/415/32-36
Olanzapine KRKA, d.d., Novo mesto
Zalasta 5 mg Tablet
EU/1/07/415/006
Olanzapine KRKA, d.d., Novo mesto
Zalasta 7.5 mg Orodispersible tablet
EU/1/07/415/37-41
Olanzapine KRKA, d.d., Novo mesto
Zalasta 7.5 mg Tablet
EU/1/07/415/11-15
Olanzapine KRKA, d.d., Novo mesto
Zyllt 75 mg film-coated tablets
EU/1/09/553/001-10
Clopidogrel hydrogensulfate KRKA, d.d., Novo mesto
7 8 9 10
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 19 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.